SS
CRBP icon

SBI Securities’s Corbus Pharmaceuticals CRBP Stock Holding History

SBI Securities’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516 Buy
55
+3
+6% +$28 ﹤0.01% 3023
2026
Q1 		$488 Hold
52
– – ﹤0.01% 2900
2025
Q4 		$423 Sell
52
-3
-5% -$37 ﹤0.01% 2930
2025
Q3 		$696 Buy
55
+1
+2% +$10 ﹤0.01% 2843
2025
Q2 		$373 Sell
54
-8
-13% -$58 ﹤0.01% 3083
2025
Q1 		$329 Sell
62
-41
-40% -$362 ﹤0.01% 3030
2024
Q4 		$1.22K Buy
+103
New +$1.73K ﹤0.01% 2522

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

SBI Securities's CRBP Position: Q2 2026 in Review

SBI Securities increased its Corbus Pharmaceuticals (CRBP) stake by 5.8% in Q2 2026, buying an estimated $28 and bringing the position to 55 shares worth $516. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

SBI Securities first reported a position in CRBP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22K in Q4 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • SBI Securities held 55 shares of Corbus Pharmaceuticals worth $516 as of Q2 2026.
  • SBI Securities bought 3 Corbus Pharmaceuticals shares in Q2 2026, an estimated $28.
  • Corbus Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3023 holding.
  • SBI Securities first reported a position in Corbus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Corbus Pharmaceuticals position peaked at $1.22K in Q4 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.